Get started
Work

Supplementary Fig. 3 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

Year: 2024
Type: supplementary-materials
Abstract: Supplementary Fig 3 In vivo cellular and humoral responses through 52 weeks are illustrated here.
DOI: 10.1158/1078-0432.27030949
Authors: Emmanuel S. Antonarakis, Sumit K. Subudhi, Christopher M. Pieczonka, Lawrence I. Karsh, David I. Quinn, Jason M. Hafron, Helen M. Wilfehrt, Matthew Harmon, Nadeem A. Sheikh, Neal D. Shore, Daniel P. Petrylak
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4402819814
Cites:
Cited by:
Related to: 10